Robinson Byron

Robinson Byron is listed in filings as Chief Strategy Officer at Janux Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 3, 2025, including 2 public disclosures. Recent filings connect the profile to Janux Therapeutics, Inc. (JANX). The current snapshot covers public activity from Jan 3, 2025. Reported amounts are shown as $5.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.